p2

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

Roles and Responsibilities of an Area Sales Manager

March 28, 2020

New Drug Approval | FDA Approves Colchicine (Lodoco) as First Anti-Inflammatory...

June 20, 2023

What is the Induction of a Medical Representative? | Free Webinar...

June 10, 2023

HOT NEWS

News & Articles

Heat Stroke | Rising Temperature | Tips to Prevent Heat Stroke

Learning and Development

Leaves – Types and Details

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Role and Responsibilities